6-methoxy-chroman-4-one oxime | 67858-18-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 6-methoxy-chroman-4-one oxime
• 英文别名: 6-Methoxy-chroman-4-on-oxim；6-methoxy-4-chromanone oxime；(NE)-N-(6-methoxy-2,3-dihydrochromen-4-ylidene)hydroxylamine
• CAS: 67858-18-8
• 化学式: C₁₀H₁₁NO₃
• 分子量: 193.202
• InChiKey: KOFJBEHYDWRMNH-PKNBQFBNSA-N

物化性质

• 熔点：
  120 °C
• 沸点：
  359.4±41.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  51
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-methoxy-chroman-4-one oxime 在 镍 氢气 作用下， 以 乙醇 为溶剂， 生成 2-[2-hydroxyethyl-(6-methoxy-3,4-dihydro-2H-chromen-4-yl)amino]ethanol
  参考文献：
  名称：

  Pratap, Ram; Gupta, R. C.; Anand, Nitya, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1981, vol. 20, # 12, p. 1063 - 1067

  摘要：

  DOI：
• 作为产物：
  描述：

  6-甲氧基-4-二氢色原酮 在 羟胺 作用下， 生成 6-methoxy-chroman-4-one oxime
  参考文献：
  名称：

  6,8-Dimethoxy-4-chromanone

  摘要：

  不可用。

  DOI：

  10.1139/v52-031

文献信息

• [EN] AMINOCHROMANE, AMINOTHIOCHROMANE AND AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY<br/>[FR] DÉRIVÉS D'AMINOCHROMANE, D'AMINOTHIOCHROMANE ET D'AMINO-1,2,3,4-TÉTRAHYDROQUINOLÉINE, COMPOSITIONS PHARMACEUTIQUES CONTENANT CEUX-CI ET LEUR UTILISATION THÉRAPEUTIQUE
  申请人：ABBOTT GMBH & CO KG

  公开号：WO2013020930A1

  公开（公告）日：2013-02-14

  The present invention relates to aminochromane, aminothiochromane and 1,2,3,4-tetrahydroquinoline derivatives of the formula (I), or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino- 1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.

  本发明涉及氨基色酮、氨基硫代色酮和1,2,3,4-四氢喹啉衍生物的化学式(I)，或其生理耐受盐。本发明涉及包含这些氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物的药物组合物，以及利用这些氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物进行治疗用途。这些氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物是GlyT1抑制剂。
• 2,3-Dihydro-4H-1-benzopyran-4-one O-Carbamoyloximes, a Series of Gastric Antisecretory Agents
  作者：George C. Wright、Thomas J. Schwan、Marvin M. Goldenberg、Ronald E. White

  DOI：10.1002/jps.2600721134

  日期：1983.11

  A series of 2,3-dihydro-4H-1-benzopyran-4-one O-carbamoyloximes were synthesized and evaluated for gastric antisecretory activity in a pylorus-ligated rat model. Various substituents in the 6-position did not afford any compounds more active than I.

  合成了一系列的2,3-二氢-4H-1-苯并吡喃-4-酮-O-氨基甲酰肟，并在幽门结扎的大鼠模型中评估了胃的抗分泌活性。6位上的各种取代基没有提供比I更活泼的化合物。
• Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
  申请人：AbbVie Deutschland GmbH & Co. KG

  公开号：US20150111867A1

  公开（公告）日：2015-04-23

  The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquin oline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.

  本发明涉及氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物的化学式（I）或其生理耐受盐。该发明涉及包括这种氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物的药物组合物，以及利用这种氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物进行治疗目的的用途。这些氨基色酮、氨基硫代色酮和氨基-1,2,3,4-四氢喹啉衍生物是GlyT1抑制剂。
• N-Benzyl-4-chromanamines
  申请人：Morton-Norwich Products, Inc.

  公开号：US04115407A1

  公开（公告）日：1978-09-19

  Certain N-benzyl-4-chromanamines are useful as anti-inflammatory agents.

  某些N-苄基-4-色苷胺可用作抗炎药。
• AMINOCHROMANE, AMINOTHIOCHROMANE AND AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY
  申请人：AMBERG Wilhelm

  公开号：US20130035323A1

  公开（公告）日：2013-02-07

  The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.

  本发明涉及公式(I)的氨基色素、氨基硫色素和氨基-1,2,3,4-四氢喹啉衍生物或其生理耐受的盐。本发明涉及包含此类氨基色素、氨基硫色素和氨基-1,2,3,4-四氢喹啉衍生物的制药组合物，以及使用此类氨基色素、氨基硫色素和氨基-1,2,3,4-四氢喹啉衍生物进行治疗的用途。氨基色素、氨基硫色素和氨基-1,2,3,4-四氢喹啉衍生物是GlyT1抑制剂。